24 related articles for article (PubMed ID: 28952222)
1. On the significance of Tim-3 expression in pancreatic cancer.
Peng PJ; Li Y; Sun S
Saudi J Biol Sci; 2017 Dec; 24(8):1754-1757. PubMed ID: 29551917
[TBL] [Abstract][Full Text] [Related]
2. Poorer survival outcomes in patients with multiple versus single primary melanoma.
Karapetyan L; Yang X; Knight AD; Huang Z; Wang H; Sander CA; Minnier CP; Wilson M; Li A; Karunamurthy A; Storkus WJ; Kirkwood JM
Cancer; 2022 Jun; 128(11):2098-2106. PubMed ID: 35319783
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment-related multigene prognostic prediction model for breast cancer.
Hong K; Zhang Y; Yao L; Zhang J; Sheng X; Guo Y
Aging (Albany NY); 2022 Jan; 14(2):845-868. PubMed ID: 35060926
[TBL] [Abstract][Full Text] [Related]
4. A Personalized Genomics Approach of the Prostate Cancer.
Iacobas S; Iacobas DA
Cells; 2021 Jun; 10(7):. PubMed ID: 34209090
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation.
Qin S; Dong B; Yi M; Chu Q; Wu K
Front Oncol; 2020; 10():1288. PubMed ID: 32850398
[No Abstract] [Full Text] [Related]
6. MicroRNA-6852 suppresses cell proliferation and invasion via targeting forkhead box J1 in gastric cancer.
Yu H; Zhang J; Wen Q; Dai Y; Zhang W; Li F; Li J
Exp Ther Med; 2018 Oct; 16(4):3249-3255. PubMed ID: 30214548
[TBL] [Abstract][Full Text] [Related]
7. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
8. Immunoregulation effects of TIM-3 on tumors.
Sheng CC; Han FY
Neoplasma; 2019 Mar; 66(2):167-175. PubMed ID: 30509105
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of T cell immunoglobulin mucin-3 in prostate cancer.
Piao YR; Piao LZ; Zhu LH; Jin ZH; Dong XZ
Asian Pac J Cancer Prev; 2013; 14(6):3897-901. PubMed ID: 23886204
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Tim-3 as a therapeutic target in prostate cancer.
Piao YR; Jin ZH; Yuan KC; Jin XS
Tumour Biol; 2014 Nov; 35(11):11409-14. PubMed ID: 25119597
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Tim-3 as a therapeutic target in prostate cancer.
Piao Y; Jin X
Tumour Biol; 2017 Jul; 39(7):1010428317716628. PubMed ID: 28681697
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative detection of DD3 mRNA in prostate cancer tissues by real-time fluorescent quantitative reverse transcription polymerase chain reaction].
Tao ZH; Mao XL; Wang CH; Chen XD; Yu KY; Weng ZL; Hu YP; Zhang XH; Xie H; Wang OC; Song QT; Li CD; Chen ZG
Zhonghua Nan Ke Xue; 2007 Feb; 13(2):130-3. PubMed ID: 17345768
[TBL] [Abstract][Full Text] [Related]
13. Multigene methylation analysis for detection and staging of prostate cancer.
Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
[TBL] [Abstract][Full Text] [Related]
14. Significance of the detection of TIM-3 and FOXJ1 in prostate cancer.
Lan Y; Hu X; Jiang K; Yuan W; Zheng F; Chen H
J BUON; 2017; 22(4):1017-1021. PubMed ID: 28952222
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
